Pantoprazole Aurobindo Pharma (Malta) (Pantoprazole)

Pantoprazole inhibits the H+/K+‑ATPase enzyme, also known as the gastric proton pump, located on the secretory surface of parietal cells. By binding irreversibly to this enzyme, it blocks the final step of acid production, leading to a sustained increase in gastric pH and allowing acid‑related lesions to heal.

The dosage of pantoprazole is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Pantoprazole should be used during pregnancy or lactation only if clearly needed after a careful risk‑benefit assessment by the prescriber. Limited data are available, and the drug crosses the placenta; it is excreted in breast milk in small amounts. Consultation with a healthcare provider is essential.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazole shares the same mechanism of action as other proton pump inhibitors such as omeprazole and esomeprazole, but it has a lower potential for drug‑drug interactions involving CYP2C19 metabolism. Its pharmacokinetic profile offers consistent acid control with once‑daily dosing for most indications.

Pantoprazole tablets should be stored at ambient temperature, below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Pantoprazole is administered orally as a tablet. It is usually taken once daily, preferably before a meal, with a glass of water. Swallow the tablet whole; do not crush, chew, or split it unless the prescriber specifically advises otherwise.

Serious risks, though rare, include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels leading to muscle cramps or cardiac arrhythmias, and an increased risk of bone fractures with long‑term use. Patients should seek immediate medical attention if they experience any of these symptoms.

Pantoprazole is contraindicated in patients with known hypersensitivity to pantoprazole or any component of the formulation. Caution is also advised for individuals with severe liver impairment, those taking certain antifungal agents, and patients on clopidogrel where reduced antiplatelet effect may be a concern.